Table 1.
Baseline general characteristics and training variables of participants.
| 2S-Hesperidin | Placebo | p-Value | |
|---|---|---|---|
| Age (years) | 35.0 (9.20) | 32.6 (8.90) | 0.407 |
| Body mass (kg) | 71.0 (6.98) | 70.4 (6.06) | 0.773 |
| Height (cm) | 175.3 (6.20) | 176.5 (6.10) | 0.541 |
| BMI (kg·m−2) | 23.1 (1.53) | 22.6 (1.43) | 0.292 |
| BF (%) | 8.9 (1.63) | 9.0 (1.64) | 0.803 |
| VO2MAX (L·min−1) | 3.99 (0.36) | 3.98 (0.63) | 0.971 |
| VO2MAX (mL·kg−1·min−1) | 57.5 (6.97) | 57.9 (9.53) | 0.880 |
| HRMAX (bpm) | 184.9 (11.11) | 183.2 (8.68) | 0.593 |
| VT1 (%) | 50.9 (5.63) | 50.0 (4.78) | 0.610 |
| VT2 (%) | 84.9 (5.85) | 84.1 (5.70) | 0.644 |
| Training variables | 2S-Hesperidin | Placebo | p-value |
| Total distance (km) | 1121.12 (534.99) | 1082.43 (810.46) | 0.868 |
| HRAVG (bpm) | 144.76 (8.88) | 137.48 (13.11) | 0.067 |
| WAVG (W) | 174.9 (15.79) | 163.5 (32.49) | 0.435 |
| RPE | 6.34 (0.82) | 6.33 (1.16) | 0.975 |
Values are expressed as mean (SD). BMI = body mass index; BF = body fat; VO2máx = maximum oxygen volume; VT1 = ventilatory threshold 1 (aerobic); VT2 = ventilatory threshold 2 (anaerobic); Total distance = of all the training sessions carried out during the study period; HRavg = average heart rate of all the training sessions carried out during the study period; Wavg = average power output of all training sessions during the study period.